Article Information
PubMed
Print ISSN
Online ISSN
History
- Received February 17, 2017
- Accepted May 31, 2017
- Published online July 10, 2017.
Article Versions
- Earlier version (June 2, 2017 - 10:02).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Hong Shen,
- Weiqi Chen,
- Dieter M. Drexler,
- Sandhya Mandlekar,
- Vinay K. Holenarsipur,
- Eric E. Shields,
- Robert Langish,
- Kurex Sidik,
- Jinping Gan,
- W. Griffith Humphreys,
- Punit Marathe, and
- Yurong Lai
- Pharmaceutical Candidate Optimization (H.S., W.C., R.L., J.G., W.G.H., P.M., Y.L.) and Global Biometrics Sciences (K.S.), Bristol-Myers Squibb Company, Princeton, New Jersey; Pharmaceutical Candidate Optimization, Bristol-Myers Squibb Company, Wallingford, Connecticut (D.M.D., E.E.S.); Bristol-Myers Squibb India Pvt. Ltd. (S.M.) and Syngene International Ltd. (V.K.H.), Biocon BMS R&D Center, Bangalore, India
- Address correspondence to:
Dr. Hong Shen, Bristol-Myers Squibb Company, Route 206 and Province Line Road, Princeton, NJ 08543-4000. E-mail: hong.shen1{at}bms.com
Statistics from Altmetric.com
Article usage
In this issue
Endogenous Biomarkers of OATP Inhibition
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement